The Caledonian-Record

Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA ® (enlicitide) tablets 20 mg as an adjunct ...

The F.D.A. Approves a New Pill to Slash Cholesterol Levels

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.
Technical.ly

Maryland is building a roadmap for state info and LLMs, using a simple text file to guide chatbot queries

With residents increasingly using AI assistants for public services, engineering head David Holmes explains how the ...
aad.org

Do facial masks work, and should I add one to my skin care routine?

Last time you shopped for skin care products, you might have noticed facial masks seem to be everywhere. Facial masks are marketed as products that can help improve your skin tone, texture, and health ...
IEEE

Predicting EV Li-Ion Battery Fires: An Integrated Approach Using Generative AI and Machine Learning Based on Vented Gas Emissions

Abstract: The booming usage of Electric Vehicles (EV) led to the augmentation of Lithium-Ion batteries. This is due to its charging speed, ease of maintenance, lower operational cost, and high ...
IEEE

Analysis of Li Ion Battery using Computational Fluid Dynamics

Abstract: This paper explores how Lithium-ion (Li-ion) battery design can be optimized through the use of Computational Fluid Dynamics (CFD) research. The purpose of this paper is to analyze thermal ...